CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- 8-K Event Unregistered share sale
- 8-K Event Executive or director change · Shareholder vote results · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- S-3 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- 10-Q Report Quarterly Report
- 4 Open-market buy 10% owner bought 1,927,937 shares
- 8-K Event Results of operations
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 10-K/A Report 10-K/A
Page 6 of 31 · 615 filings